SCHEMBL102205

SCHEMBL102205

Fc1ccc(Br)nc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29382753 1.00
Formaldehyde SCHEMBL29240890 0.93 FDFT1 (0.39)
SCHEMBL2824810 0.82 PDGFRB (0.40)
SCHEMBL16345402 0.75 MEN1 (0.44)
SCHEMBL15522598 0.74 MAP4K4 (0.40)
SCHEMBL787481 0.73 CYP19A1 (0.44)
SCHEMBL29740319 0.73 CYP19A1 (0.44)
SCHEMBL10633324 0.73 NR3C1 (0.41)
SCHEMBL10627287 0.73 NPC1 (0.62)
SCHEMBL7880596 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3158 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4716683-A1 PROCESS AND INTERMEDIATES FOR THE PREPARATION OF A P2X3 INHIBITOR Chiesi Farmaceutici S.p.A. (IT) 2026-04-01 EP claimed
US-12209086-B2 FGFR3 inhibitor compounds ELI LILLY AND COMPANY (US) 2025-01-28 US claimed
WO-2024240728-A1 PROCESS AND INTERMEDIATES FOR THE PREPARATION OF A P2X3 INHIBITOR CHIESI FARMACEUTICI S.P.A. (IT) 2024-11-28 WO claimed
US-20240190870-A1 FGFR3 INHIBITOR COMPOUNDS LOXO ONCOLOGY, INC. 2024-06-13 US claimed
CN-116510644-A Synthesis method of trifluoromethyl substituted fluorine-containing heterocyclic formic acid 烟台宁远药业有限公司 2023-08-01 CN claimed
CN-114773391-A Fluorine-containing transition metal complex, preparation method and application thereof 联碳新材料技术(杭州)有限公司 2022-07-22 CN claimed
CN-106117134-A The synthetic method of medical material 5-fluoro-2-bromine isonicotinic acid 无锡乾浩生物医药有限公司 2016-11-16 CN claimed
WO-2008054284-A1 A NEW PROCESS FOR THE PRODUCTION OF 5-FLUORO-PYRIDINE-2- CARBONITRILE AND 5-FLUORO-N-HYDROXY-PYRIDINE-2- CARBOXAMIDINE. ASTRAZENECA AB (SE) 2008-05-08 WO claimed
CN-122079985-A FGFR3 inhibitor compounds 2026-05-26 CN disclosed
CN-122079984-A FGFR3 inhibitor compounds 2026-05-26 CN disclosed
CN-122079983-A FGFR3 inhibitor compounds 2026-05-26 CN disclosed
US-12637451-B2 Amino quinazoline derivatives as P2X3 inhibitors CHIESI FARMACEUTICI S.P.A. (IT) 2026-05-26 US disclosed
WO-2026106499-A1 OREXIN RECEPTOR ANTAGONISTS: 2-AZABICYCLIC COMPOUNDS BIAL - PORTELA & CA., S.A. (PT) 2026-05-21 WO disclosed
CN-115650982-B Compounds for imaging TAU protein aggregates AC免疫有限公司 2026-05-19 CN disclosed
WO-2002038568-A1 IMIDAZO-TRIAZINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS MERCK SHARP & DOHME LIMITED (GB) 2002-05-16 WO disclosed
WO-2002010154-A2 SUBSTITUTED HETEROCYCLIC AMIDES ELI LILLY AND COMPANY (US) 2002-02-07 WO disclosed
US-4457927-A Pyrido[2,1-b]quinazolinone derivatives and the preparation and use thereof SCHERING, AKTIENGESELLSCHAFT (DE) 1984-07-03 US disclosed
EP-0011142-B1 PYRIDO (2,1-B) QUINAZOLINONES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SCHERING AKTIENGESELLSCHAFT (DE) 1982-12-29 EP disclosed
EP-0011142-A1 Pyrido (2,1-b) quinazolinones, their preparation and pharmaceutical compositions containing them SCHERING AKTIENGESELLSCHAFT (DE) 1980-05-28 EP disclosed
US-3947457-A Method for preparing 2,5-dihalo- and 2,5,6-trihalopyridines THE DOW CHEMICAL COMPANY (US) 1976-03-30 US disclosed